Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

AerWave announced today that it completed the first-in-human feasibility study of its disease-modifying ultrasound lung ...

Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...

Chronic obstructive pulmonary disease (COPD) is a serious health condition that can cause severe complications for the lungs, ...

The Ministry of Public health (MoPH) is intensifying efforts to raise awareness about asthma and chronic obstructive ...

Truist raised the firm’s price target on Verona Pharma (VRNA) to $57 from $44 and keeps a Buy rating on the shares. The firm cites the ...